Oral and intravenous vinorelbine plus trastuzumab for 1st-line treatment of HER2-overexpressing metastatic breast cancer (MBC). A trial of the german AIO breast cancer group

Metastatic Breast ◽

Line Treatment ◽

Cancer Group ◽

Breast Cancer Group

International comparison of treatment and survival of older patients with primary metastatic breast cancer (PMBC) – a population-based cohort study from the EURECCA Breast Cancer Group

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2019.11.477 ◽

2020 ◽

Vol 46 (2) ◽

pp. e22

Author(s):

Iris Noordhoek ◽

Esther Bastiaannet ◽

Liesbet van Eycken ◽

Sabine Siesling ◽

Paul Walsh ◽

...

Keyword(s):

Breast Cancer ◽

Cohort Study ◽

International Comparison ◽

Older Patients ◽

Metastatic Breast ◽

Population Based ◽

Cancer Group ◽

Breast Cancer Group

Abstract P6-10-05: First-line chemotherapy versus first-line endocrine therapy in hormone receptor positive HER2 negative patients with metastatic breast cancer in China: Results of the study of breast cancer group of the Chinese Society of Clinical Oncology (CSCO)

10.1158/0008-5472.sabcs13-p6-10-05 ◽

2013 ◽

Author(s):

T Wang ◽

TT Yang ◽

LJ Yang ◽

HY Song ◽

CQ Ouyang ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Metastatic Breast ◽

Chinese Society ◽

First Line ◽

Cancer Group ◽

Hormone Receptor Positive ◽

Breast Cancer Group ◽

Line Chemotherapy

Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group

British Journal of Cancer ◽

10.1038/s41416-018-0090-1 ◽

2018 ◽

Vol 119 (1) ◽

pp. 121-129 ◽

Cited By ~ 17

Author(s):

Marloes G. M. Derks ◽

◽

Esther Bastiaannet ◽

Mandy Kiderlen ◽

Denise E. Hilling ◽

...

Keyword(s):

Breast Cancer ◽

Cohort Study ◽

Older Patients ◽

Metastatic Breast ◽

Population Based ◽

European Countries ◽

Cancer Group ◽

Breast Cancer Group

Faculty of 1000 evaluation for Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976445.793471388 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Phase 3 ◽

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study

BMC Research Notes ◽

10.1186/1756-0500-5-162 ◽

2012 ◽

Vol 5 (1) ◽

Cited By ~ 2

Author(s):

Lamiaa Boulaamane ◽

Saber Boutayeb ◽

Hassan Errihani

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2082-4 ◽

2013 ◽

Vol 71 (4) ◽

pp. 913-919 ◽

Cited By ~ 16

Author(s):

Hesham Tawfik ◽

Yousri Rostom ◽

Hesham Elghazaly

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdq122 ◽

2010 ◽

Vol 21 (12) ◽

pp. 2305-2315 ◽

Cited By ~ 23

Author(s):

A. Chan ◽

D.W. Miles ◽

X. Pivot

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Abstract PS12-21: First-line treatment of hormone receptor positive metastatic breast cancer (MBC) in everyday practice: Results from the Austrian AGMT_MBC-Registry

10.1158/1538-7445.sabcs20-ps12-21 ◽

2021 ◽

Author(s):

Gabriel Rinnerthaler ◽

Simon P Gampenrieder ◽

Christoph Tinchon ◽

Andreas Leo Petzer ◽

Christoph Suppan ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Metastatic Breast ◽

Everyday Practice ◽

Line Treatment ◽

First Line ◽

Hormone Receptor Positive ◽

Epirubicin-Vinorelbine Intravenous Combination Followed by Oral Vinorelbine as First-Line Treatment in Metastatic Breast Cancer

Tumori Journal ◽

10.1177/030089160709300605 ◽

2007 ◽

Vol 93 (6) ◽

pp. 544-549 ◽

Cited By ~ 3

Author(s):

Antonio Ardizzoia ◽

Ilaria Colombo ◽

Monica Giordano ◽

Stefania Aglione ◽

Luciano Isa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Oral Vinorelbine ◽